FLGT Q3 2021 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

Q3 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$228M+124.0% YoY

Gross Profit

$184M80.9% margin

Operating Income

$159M69.9% margin

Net Income

$123M53.8% margin

EPS (Diluted)

$3.93

QoQ Revenue Growth

+48.3%

Cash Flow

Operating Cash Flow

$152M

Free Cash Flow

$149M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$160M

Stockholders' Equity

$1.0B

Cash & Equivalents

$215M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$228M	$102M	+124.0%
Gross Profit	$184M	$75M	+144.4%
Operating Income	$159M	$64M	+150.7%
Net Income	$123M	$47M	+162.7%

Geographic Segments

U S

$224M98%

Non Us

$4M2%